Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 13.7M | 13.0M | 9.7M | 7.9M |
| Selling general and admin | 4.4M | 4.0M | 3.2M | 3.0M |
| Other operating expenses | — | — | — | — |
| Operating income | -18.1M | -17.0M | -13.0M | -10.9M |
| Non operating interest income | ||||
| Income | 2.3M | 2.5M | 2.7M | 2.0M |
| Expense | — | 0 | 0 | 0 |
| Other income expense | -130K | -46K | -34K | -66K |
| Pretax income | -16.0M | -14.6M | -10.3M | -9.0M |
| Tax provision | — | 0 | 0 | 0 |
| Net income | -16.0M | -14.6M | -10.3M | -9.0M |
| Basic EPS | -0.6 | -0.6 | -0.4 | -0.4 |
| Diluted EPS | -0.6 | -0.6 | -0.4 | -0.4 |
| Basic average shares | 25.9M | 25.8M | 25.7M | 23.4M |
| Diluted average shares | 25.9M | 25.8M | 25.7M | 23.4M |
| EBITDA | -18.0M | -14.5M | -10.2M | -9.0M |
| Net income from continuing op. | -16.0M | -14.6M | -10.3M | -9.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | 0 | 0 |